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Abstract
Containment of Mycobacterium tuberculosis (Mtb) infection requires T cell recognition of
infected macrophages. Mtb has evolved to tolerate, evade, and subvert host immunity.
Despite a vigorous and sustained CD8+ T cell response during Mtb infection, CD8+ T cells
make limited contribution to protection. Here, we ask whether the ability of Mtb-specific T
cells to restrict Mtb growth is related to their capacity to recognize Mtb-infected macro-
phages. We derived CD8+ T cell lines that recognized the Mtb immunodominant epitope
TB10.44−11 and compared them to CD4+ T cell lines that recognized Ag85b240-254 or
ESAT63-17. While the CD4+ T cells recognized Mtb-infected macrophages and inhibited
Mtb growth in vitro, the TB10.4-specific CD8+ T cells neither recognized Mtb-infected
macrophages nor restricted Mtb growth. TB10.4-specific CD8+ T cells recognized macro-
phages infected with Listeria monocytogenes expressing TB10.4. However, over-expres-
sion of TB10.4 in Mtb did not confer recognition by TB10.4-specific CD8+ T cells. CD8+ T
cells recognized macrophages pulsed with irradiated Mtb, indicating that macrophages
can efficiently cross-present the TB10.4 protein and raising the possibility that viable
bacilli might suppress cross-presentation. Importantly, polyclonal CD8+ T cells specific
for Mtb antigens other than TB10.4 recognized Mtb-infected macrophages in a MHC-
restricted manner. As TB10.4 elicits a dominant CD8+ T cell response that poorly recog-
nizes Mtb-infected macrophages, we propose that TB10.4 acts as a decoy antigen. More-
over, it appears that this response overshadows subdominant CD8+ T cell response that
can recognize Mtb-infected macrophages. The ability of Mtb to subvert the CD8+ T cell
response may explain why CD8+ T cells make a disproportionately small contribution to
host defense compared to CD4+ T cells. The selection of Mtb antigens for vaccines has
focused on antigens that generate immunodominant responses. We propose that estab-
lishing whether vaccine-elicited, Mtb-specific T cells recognize Mtb-infected macro-
phages could be a useful criterion for preclinical vaccine development.
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Author summary
Immunodominant antigens elicit a large majority of T cells during an infection, and it is
presumed that these T cells go on to recognize infected cells. Immunodominant antigens
produced by Mycobacterium tuberculosis (Mtb) have been incorporated into vaccines, but
whether T cells specific for these antigens recognize Mtb-infected cells is inconsistent.
One of these is TB10.4 (EsxH), and after aerosol infection in mice, up to 40% of lung CD8
T cells recognize TB10.4. Vaccination with TB10.44−11 peptide elicits a robust response
and TB10.4-specific memory CD8 T cells develop. However, these mice are not protected
against Mtb challenge. In trying to understand why this vaccine fails, we discovered that
TB10.4-specific CD8 T cells do not recognize Mtb-infected macrophages in vitro. In con-
trast, under identical conditions, Ag85b-specific CD4 T cells recognize Mtb-infected mac-
rophages and inhibit Mtb growth. In contrast, polyclonal CD4 and CD8 T cells from the
lungs of infected mice recognize Mtb-infected macrophages, suggesting macrophages
present antigens other than the immunodominant TB10.4 antigen. Thus, we conclude
that TB10.4 is a decoy antigen that elicits a dominant CD8 T cell response that poorly rec-
ognizes Mtb-infected macrophages, and allows Mtb to evade CD8 immunity. Instead, this
response may benefit Mtb by promoting inflammation. We propose that the poor ability
of CD8 T cells to mediate protection might arise because the dominant T cells are unable
to recognize infected macrophages. Identifying antigens that are presented by infected
cells should be prioritized, as their inclusion in vaccines may enhance the expansion of T
cells that mediate protection.
Introduction
Unlike most disease-causing pathogens, Mycobacterium tuberculosis (Mtb), the cause of tuber-
culosis (TB), persists in humans because of its highly evolved ability to evade and subvert the
host immunity [1]. Mtb subverts vesicular trafficking, prevents phagolysosome fusion, and rep-
licates in an intracellular niche within macrophages, allowing it to evade detection by humoral
immunity [2]. Mtb also delays the initiation and recruitment of T cell immunity to the lung,
promoting the establishment of a persistent infection [3]. Despite these challenges, T cell immu-
nity does occur and plays an essential role in controlling the infection in both mice and humans
[3–5]. With 10 million new TB cases annually, an effective vaccine would offer a cost-effective
way to prevent TB and attenuate this persistent global pandemic. Given the importance of T
cells during host defense, strategies for TB vaccines largely aim at generating memory T cells
rather than neutralizing antibodies. Most subunit vaccines incorporate immunodominant Mtb
antigens, which elicit large T cell responses [6]. Several immunodominant antigens have been
identified in the murine TB model, including Ag85a, Ag85b, CFP-10, ESAT-6 and TB10.4 [7]. T
cell responses to these antigens are also frequently detectable in Mtb-infected people, and these
highly prevalent responses represent the basis for TB immunodiagnostic tests [8]. By incorpo-
rating these immunodominant antigens into vaccines, the expectation is that antigen-specific T
cells will contain the infection before Mtb can establish a niche and evade host immunity [6].
T cell recognition of Mtb-infected macrophages is fundamental to containment of TB infec-
tion. Srivastava et al elegantly showed this by using mixed bone marrow (BM) chimeric mice
made from wild type (WT) and major histocompatibility complex class II (MHC class II) deficient
BM [9]. Following infection, polyclonal CD4+ T cells suppressed Mtb growth more efficiently in
MHC class II-expressing cells than in MHC class II-deficient cells. This data convincingly argues
T cell recognition of Mtb-infected macrophages
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that cognate recognition (i.e., T cell receptor (TCR) mediated recognition) of infected cells by
polyclonal CD4+ T cells limits bacterial growth. However, whether this protection comes from T
cells recognizing immunodominant or subdominant antigens remains unknown. In fact, even
though many presume that Mtb-infected cells present immunodominant antigens, the data vali-
dating this assumption is surprisingly inconsistent. While there is consensus that Mtb-infected
cells present ESAT-6, the data concerning Ag85b presentation is more complicated [10–13].
Ag85b240-254 elicits a CD4
+ T cell response early after infection, but Mtb reduces Ag85b produc-
tion within three weeks after in vivo infection [12]. Thus, while Ag85b240-254-specific CD4
+ T cells
can recognize dendritic cells (DC) from infected mice 14 days post infection [14], there is little
recognition of Mtb-infected cells by Ag85b240-254-specific CD4
+ T cells in vivo by day 21 [12]. Fur-
thermore, Mtb has other mechanisms to evade T cell recognition, including dysregulating MHC
class II expression and inhibiting antigen presentation by stimulating antigen export by the
infected antigen presenting cells (APCs) [1, 12, 13, 15]. Whether the immunodominant antigens
recognized by CD8+ T cells are presented by Mtb-infected macrophages remains unknown. Here,
we investigated cognate T cell recognition of Mtb-infected macrophages by CD8+ T cells specific
to the immunodominant antigen TB10.4.
TB10.4 (EsxH) is an ESAT-6-like protein secreted by the ESX-3 type VII secretion system,
important in iron and zinc acquisition, and although its requirement for bacterial growth
depends on the culture conditions, it is essential for Mtb growth in macrophages and virulence
in vivo [16–18]. Following Mtb infection, TB10.4 is a target of CD4+ and CD8+ T cell responses
in humans and mice [19–23]. In Mtb-infected mice, TB10.4 elicits immunodominant responses
in both BALB/c and C57BL/6 mice, and 30–50% of lung CD8+ T cells are specific to single epi-
topes [19, 20]. We previously isolated TB10.4-specific CD8 T cells using Kb/TB10.44−11 tetra-
mers, followed by single cell sorting and PCR to identify the TB10.44−11-specific TCRs. These
TCRs were cloned in retroviral vectors to produce retrogenic (Rg) mice [20]. Following transfer
to Mtb-infected mice, naïve (CD44loCD62Lhi) TB10.44−11-specific Rg CD8 T cells became acti-
vated first in the LN and then trafficked to the lung, where they matured into effector CD8 T
cells [20, 24]. Whether these TB10.4-specific CD8+ T cells can mediate protection is unclear.
Adoptive transfer of TB10.4-specific CD8+ T cells into Mtb-infected, immunocompromised
mice reduces the bacterial burden and promotes host survival [20]. However, despite eliciting
large numbers of TB10.4-specific CD8+ T cells, a vaccine incorporating the H-2 Kb-restricted
epitope, TB10.44−11, fails to protect mice from Mtb infection [24]. We hypothesize that the
inability of TB10.4-specific CD8+ T cells to mediate protection is due to inefficient recognition
of Mtb-infected macrophages.
We used primary CD4+ and CD8+ T cells lines to investigate the recognition of Mtb-infected
macrophages by T cells specific to Ag85b, ESAT-6, or TB10.4. Ag85b- and ESAT-6-specific
CD4+ T cells recognized Mtb-infected macrophages, but under the same conditions, TB10-speci-
fic CD8+ T cells did not recognize infected macrophages or inhibit bacterial growth. This was
true even upon examination of numerous conditions and permutations including length of infec-
tion, duration of T cell and macrophage co-culture, and multiplicity of infection. TB10.4-specific
CD8+ T cells did recognize macrophages infected with recombinant Listeria monocytogenes
expressing TB10.4, but only if the bacilli could escape into the cytosol. However, overexpressing
TB10.4 in Mtb did not confer recognition. Importantly, macrophages pulsed with irradiated bac-
teria efficiently cross-presented TB10.4 to CD8+ T cells, suggesting that live Mtb actively inhib-
ited presentation. Interestingly, polyclonal CD8+ T cells specific for Mtb antigens other than
TB10.4 recognized Mtb-infected macrophages in a MHC class I-restricted manner. Thus, while
TB10.4-specific CD8+ T cells do not recognize Mtb-infected macrophages, there exist other
CD8+ T cells that recognize subdominant antigens presented by Mtb-infected cells. Based on
these data, we propose that TB10.4 is a decoy antigen: it elicits a massive and persistent CD8+ T
T cell recognition of Mtb-infected macrophages
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cell response, which cannot recognize Mtb-infected macrophages. Such a decoy antigen may dis-
tract the CD8+ response from focusing on subdominant antigens presented by infected cells,
leading to evasion from host immunity.
Results
TB10.4-specific CD8+ and Ag85b-specific CD4+ T cell lines sensitively
recognize their cognate antigens
To study T cell recognition of Mtb-infected macrophages, we established antigen-specific T
cell lines, which unlike T cell hybridomas, facilitate the study of T cell function as well as
recognition. The TB10.44−11-specific CD8
+ T cell line, referred to hereafter as TB10Rg3, has
a distinct TCR cloned originally from TB10.44−11-tetramer
+ CD8+ T cells isolated from
infected mice and expressed in retrogenic mice [20]. The Ag85b240-254-specific CD4
+ T cell
line, referred to hereafter as P25 cells, was derived from P25 TCR transgenic mice [25]. To
confirm their antigen-specificity, we co-cultured the P25 or TB10Rg3 T cells with thiogly-
colate-elicited peritoneal macrophages (TGPMs) pulsed with or without their cognate pep-
tides and then measured their expression of CD69 and Nur77. While both CD69 and Nur77
are T cell activation markers, increases in Nur77 expression indicate TCR-mediated activa-
tion more specifically [26, 27]. After co-culture with TGPMs pulsed with Ag85b240-254 pep-
tide, Nur77 expression by P25 cells peaked after 2 hours (Fig 1A and 1B), while CD69
expression continued to increase (Fig 1C and 1D). TB10Rg3 T cells exhibited similar Nur77
and CD69 expression patterns after their co-culture with TGPMs pulsed with the TB10.44
−11 peptide (IMYNYPAM) but not with a control peptide (IMANAPAM) (Fig 1E–1H).
Since the increase in Nur77 expression was transient, we next tested whether CD69 and
IFNγ could be useful markers of antigen recognition for longer experiments. During 72
hours of co-culture with peptide-pulsed TGPMs, P25 and TB10Rg3 T cells continued to
express CD69 and secreted IFNγ in a peptide dose-dependent manner (Fig 1I–1L). P25 T
cells also responded specifically to macrophages pulsed with Ag85b peptides and not
TB10.4 peptides (S1 Fig). These experiments show that P25 and TB10Rg3 T cells can recog-
nize their cognate antigens presented by TGPMs, both in short-term and long-term co-cul-
ture assays.
Ag85b-specific CD4+ T cells, but not TB10.4-specific CD8+ T cells, restrict
intracellular bacterial replication
Given that a primary function of T cells during Mtb infection is to restrict bacterial growth,
we determined whether these T cell lines could limit intracellular mycobacterial growth in
vitro. We infected TGPMs with H37Rv, a virulent Mtb strain that expresses both TB10.4
and Ag85b in vitro [22, 28]. To assess whether any bacterial growth inhibition observed was
dependent on cognate recognition, we infected both MHC-matched (i.e., H-2b) and mis-
matched (i.e., H-2k) macrophages. T cells were added on day 1 post-infection, and the num-
ber of colony forming units (CFU) was assayed 96 hours later. In the absence of T cells, Mtb
grew significantly (p<0.01) (Fig 2). P25 T cells significantly inhibited intracellular bacterial
growth in H37Rv-infected TGPMs (p<0.0001). Addition of Ag85b peptide to the infected
macrophages did not further enhance the ability of P25 T cells to inhibit bacterial growth,
suggesting that their activation was maximal. As expected, P25 T cells only inhibited bacte-
rial growth in MHC-matched macrophages, indicating that growth inhibition mediated by
T cells required cognate recognition under these conditions.
T cell recognition of Mtb-infected macrophages
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In contrast, TB10Rg3 T cells did not inhibit bacterial growth (Fig 2). We considered
whether the inability of TB10Rg3 to inhibit bacterial growth was due to a lack of recognition of
the infected macrophages or a defect in the T cells’ effector functions. When Mtb-infected
TGPMs were pulsed with the TB10.44−11 peptide for one hour prior to adding the T cells,
TB10Rg3 T cells significantly reduced bacterial growth (p<0.0001) (Fig 2A). Thus, under the
same conditions where P25 T cells significantly suppressed intracellular Mtb growth in a
MHC-restricted manner, TB10Rg3 T cells failed to inhibit bacterial growth.
We next considered whether the inability of TB10Rg3 to restrict intracellular bacterial
growth was true for other TB10.44−11-specific CD8
+ T cells. To obtain TCRs representative of
Fig 1. TB10.4-specific CD8+ (TB10Rg3) and Ag85b-specific CD4+ (P25) T cells both recognize their cognate peptides. (a) Representative histogram of Nur77
expression in P25 T cells after 2 hours of co-culture with macrophages and (b) time course of Nur77 MFI in P25 T cells. (c) Representative histogram of CD69 in P25 T
cells after 2 hours of co-culture with macrophages and (d) time course of CD69 MFI in P25 T cells. (e) Representative histogram of Nur77 in TB10Rg3 T cells after 2 hours
of co-culture and (f) time course of Nur77 MFI in TB10Rg3 T cells. (g) Representative histogram of CD69 in TB10Rg3 T cells at 2 hours of co-culture with macrophages
and (h) time course of CD69 MFI in TB10Rg3 T cells. (i) CD69 MFI and (j) IFNγ production by P25 T cells after 72 hours of co-culture. (k) CD69 MFI and (l) IFNγ
production by TB10Rg3 cells after 72 hours of co-culture. MFI, mean fluorescence intensity; mφ, macrophage.
https://doi.org/10.1371/journal.ppat.1007060.g001
T cell recognition of Mtb-infected macrophages
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other clonally expanded TB10.44−11-specific CD8
+ T cells, TB10.44−11-tetramer
+ CD8+ T cells
from Mtb-infected C57BL/6 mice were single cell sorted, and both the TCR CDR3α and
CDR3β regions were sequenced (S2 Fig). Three TCRs representative of clonally expanded T
Fig 2. Ag85b-specific CD4+ T cells, but not TB10.4-specific CD8+ T cells, inhibit bacterial growth in vitro. (a) Matched (H-2b) or
mismatched (H-2k) macrophages were infected with H37Rv for 2 hours, and then, one day post-infection, T cells were added.
Separately, TB10.4 or Ag85b peptide was added to Mtb-infected (H-2b) macrophages, and then T cells were added. CFU were
determined 4 days later. (b) C57BL/6 macrophages were infected with H37Rv as described above. The next day, TB10.44−11 peptide
and Ag85b240-254 peptide was added for 1 hour, indicated as “+,” to wells that would later receive TB10.44−11-specific CD8
+ and P25
CD4+ T cells, respectively. Subsequently, unbound peptides were washed away and TB10Rg3, TB10RgP, TB10RgL, TB10RgR, or P25
T cells were added. CFUs were determined 4 days later. Results are representative of at least three experiments. Statistical testing was
by one-way ANOVA, using the Dunnett posttest compared to d5. , #, p<0.05; , p<0.01; , p<0.005; , p<0.0001.
https://doi.org/10.1371/journal.ppat.1007060.g002
T cell recognition of Mtb-infected macrophages
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cells (TB10RgL, TB10RgR, and TB10RgQ) were cloned (S2 Fig). In addition, a fourth TCR
(TB10RgP), not previously identified by NexGen sequencing, was also cloned. All these TCRs
responded specifically to the TB10.44−11 epitope and expressed TCRs distinct from TB10Rg3
(S3 Fig). We generated T cell lines from these retrogenic mice, as described for TB10Rg3.
TB10RgP, TB10RgL, and TB10RgR did not inhibit bacterial growth (Fig 2B). However, if the
Mtb-infected macrophages were pulsed with the TB10.44−11 peptide before T cell addition,
then TB10RgP, TB10RgL, and TB10RgR T cells all inhibited bacterial growth significantly (Fig
2B). Since TB10.44−11-specific CD8
+ T cells only inhibited bacterial growth when their cognate
peptide was added to Mtb-infected macrophages, we conclude that, although they express the
effector function required to restrict intracellular bacterial growth, these TB10.44−11-specific
CD8+ T cells do not recognize Mtb-infected macrophages.
Ag85b-specific CD4+ T cells, but not TB10.4-specific CD8+ T cells,
recognize Mtb-infected macrophages
To further investigate TB10Rg3 and P25 T cells recognition of Mtb-infected cells, we next
investigated the kinetics of Mtb antigen presentation. After Mtb infection, TGPMs were cul-
tured for various lengths of time before adding the T cells. To assay antigen presentation, we
added the T cells for two hours and then measured Nur77 and CD69 (see Fig 1 for kinetics).
We first examined recognition on day 0 by adding T cells immediately after infection, and we
infected macrophages at a high MOI (average effective MOI of 1.57 to 1.62) to ensure that a
large amount of bacterial and antigens may be present. P25 T cells recognized Mtb-infected
macrophages based on the induction of Nur77 and CD69 (Fig 3A and 3B). Under these condi-
tions, there was no increase in Nur77 or CD69 expression by TB10Rg3 T cells (Fig 3C and
3D). We next chose later time points, which might allow Mtb to adapt to the intracellular envi-
ronment and potentially let the TB10.4 antigen accumulate. We first infected cells at a lower
MOI (average effective MOI of 0.2 to 0.8). TB10Rg3 T cells were added to infected macro-
phages on days 1, 3, or 5 post-infection. Again, we did not observe any increase in Nur77 or
CD69 expression (Fig 3E and 3F). As a control for T cell health and function, we co-cultured
TB10.44−11-peptide-pulsed-, uninfected-macrophages with the TB10Rg3 T cells and observed
significant increases in their Nur77 and CD69 expression (Fig 3). We also considered whether
a higher MOI may lead to more presentation. We infected macrophages at an average effective
MOI of 1.65 to 5.98 and added TB10Rg3 T cells 1 or 2 days post infection. Again, we did not
detect induction of Nur77 or CD69 expression when TB10Rg3 T cells were co-cultured with
the highly infected macrophages (S4 Fig). We did not examine recognition at high MOI on
days later than day 2 because of excessive death of the macrophages. Instead, we explored an
alternative approach to increasing antigen abundance, as described below.
Despite assessing recognition on multiple days, we considered whether the short assay
period (i.e. 2 hours) might not detect recognition of Mtb-infected macrophages by TB10Rg3 T
cells, especially if presentation of TB10.4 is inefficient or asynchronous. Therefore, we used
IFNγ production as a cumulative indicator of T cell activation during a 72-hour co-culture
experiment. Since cytokine-driven activation (e.g., IL-12, IL-18) can stimulate IFNγ produc-
tion by T cells independently of TCR signaling, we used MHC-matched (H-2b) or mismatched
(H-2k) TGPM to assess cognate recognition [27, 29–31]. As the infectious dose (MOI, multi-
plicity of infection) increased, P25 T cells produced more IFNγ when co-cultured with MHC-
matched, but not MHC-mismatched, Mtb-infected TGPMs (Fig 3G). In contrast, TB10Rg3 T
cells did not produce IFNγ when co-cultured with Mtb-infected TGPMs (Fig 3H). As before,
TB10Rg3 T cells produced IFNγ when co-cultured with uninfected macrophages pulsed with
the TB10.44−11 peptide (Fig 3H).
T cell recognition of Mtb-infected macrophages
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We next used the TB10.44−11-specific CD8
+ T cell lines TB10RgP, TB10RgL and TB10RgR
to address whether TB10.44−11-specific CD8
+ T cells other than TB10Rg3 can recognize Mtb-
infected macrophages. While the TB10RgP, TB10RgL, and TB10RgR CD8+ T cell lines pro-
duced IFNγ when cultured with uninfected macrophages pulsed with the TB10.44−11 peptide,
none produced IFNγ following a 72-hour co-culture with Mtb-infected macrophages (Fig 3I).
These data show that, regardless of the time point of T cell addition or the length of co-culture,
P25 T cells, but not TB10.44−11-specific CD8
+ T cells, recognized Mtb-infected macrophages,
based on their increased Nur77 and CD69 expression as well as their IFNγ production.
TB10.4-specific CD8+ T cells do not recognize lung cells from Mtb-infected
mice
During in vivo infection, Mtb infects a variety of myeloid cells, and this diversity changes over
the course of the infection [32–34]. We considered that lung myeloid cells from Mtb-infected
mice are more physiologically relevant than TGPMs. Thus, we isolated MHC class II+ lung
cells from Erdman-infected, RAG-1-deficient mice 4 weeks post-infection and tested their
ability to present Mtb antigens to TB10Rg3 T cells. We used RAG-1-deficient mice because of
the possibility that CD8+ T cells in the lungs of Mtb-infected, wild type mice may recognize
and eliminate any lung cells presenting the TB10.4 antigen. Since Mtb downregulates Ag85b
expression by 3 weeks post infection [11, 12], we used an ESAT-6-specific CD4+ T cell line
derived from C7 transgenic mice, which we refer to as C7 T cells [10, 35]. The immunodomi-
nant antigen ESAT-6 retains high levels of expression throughout infection and elicits a domi-
nant CD4+ T cell response in C57BL/6 mice [11]. Due to the difficulty in obtaining large
numbers of MHC class II+ cells from uninfected, RAG-1-deficient mice, we used TGPMs from
age-matched, RAG-1-deficient mice as a source of uninfected, inflammatory macrophages.
We stained C7 or TB10Rg3 T cells with 5uM of the proliferation dye eFluor450 (eBioscience)
before co-culturing them with the lung myeloid cells. After 72 hours, we measured the T cell
proliferation as a marker of T cell recognition. C7 T cells proliferated extensively when co-cul-
tured with the infected lung myeloid cells but not when co-cultured with uninfected TGPMs
(Fig 4A and 4B). In contrast, TB10Rg3 T cells did not proliferate when co-cultured with the
lung myeloid cells (Fig 4C and 4D). To assess whether TB10Rg3 T cells could proliferate if
TB10.4 was present, we pulsed the lung APCs with the TB10.44−11 peptide for 1 hour before
adding the TB10Rg3 T cells. As predicted, TB10Rg3 T cells proliferated after 72 hours of co-
culture with peptide-pulsed, lung myeloid cells (Fig 4C and 4D).
We considered the possibility that Mtb in lung myeloid cells may not grow well in vitro,
leading to altered antigen abundance that could affect T cell recognition. To address this possi-
bility, we measured the bacterial burden in the lung myeloid cells. There was a 3-fold increase
in the bacterial numbers between the beginning (d1) and the end (d4) of the experiment, indi-
cating that the bacteria remained viable (Fig 4E). Together, these data indicate that, under the
Fig 3. Ag85b-specific CD4+ T cells, but not TB10.4-specific CD8+ T cells, recognize Mtb-infected macrophages. (a-d) T cells were co-cultured with peptide-
pulsed, Mtb-infected (at MOI 1, 5, or 10), or uninfected macrophages for 2 hours. (a) Representative histogram of Nur77 expression in P25 T cells and the
normalized Nur77 MFI. (b) Representative histogram of CD69 expression in P25 T cells and the normalized CD69 MFI. (c) Representative histogram of Nur77
in TB10Rg3 T cells and the normalized Nur77 MFI. (d) Representative histogram of CD69 expression in TB10Rg3 T cells and the normalized CD69 MFI. (e-f)
TB10Rg3 T cells were co-cultured with uninfected, peptide-pulsed, or Mtb-infected macrophages for 2 hours on d1, d3, and d5 post infection. Normalized
expression of (e) Nur77 or (f) CD69 by TB10Rg3 T cells. P25 (g) or TB10Rg3 (h) T cells were co-cultured with uninfected, peptide-pulsed, or Mtb-infected
macrophages, and IFNγ production was measured after 72 hours. (i) TB10Rg3, TB10RgP, TB10RgL, TB10RgR, or P25 T cells were cultured with uninfected,
Mtb-infected, or peptide-pulsed macrophages. After 3 days, IFNγ in the supernatants was measured. Figures are representative of at least 5 (a-d, TB10Rg3), 2 (a-
d, P25), 3 (e-h), or 2 (i) experiments. Statistical analysis was done by one-way ANOVA with Dunnett posttest (a-d) or two-way ANOVA with Sidak posttest (g-
h). , p<0.05; , p<0.01; and , p<0.005.
https://doi.org/10.1371/journal.ppat.1007060.g003
T cell recognition of Mtb-infected macrophages
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1007060 May 21, 2018 9 / 30
conditions in which C7 T cells recognized lung myeloid cells from Mtb-infected mice,
TB10Rg3 T cells did not recognize these lung myeloid cells.
TB10Rg3 CD8+ and P25 CD4+ T cells recognize macrophages infected with
TB10.4-or Ag85b-expressing Listeria
We next investigated whether the location of the antigen might affect the presentation of
TB10.4 since the MHC class I antigen presentation pathway primarily samples the cytosol,
whereas Mtb is a classic phagosomal pathogen. TB10.4-specific CD8+ T cells are primed and
expanded during Mtb infection, so the TB10.4 antigens must be cross-presented; however,
whether Mtb-infected macrophages can competently cross-present mycobacterial antigens is
unknown. We investigated these possibilities using4LLO or4ActA mutant strains of Listeria
monocytogenes engineered to express the full length TB10.4 protein, hereafter referred to as
Fig 4. TB10Rg3 CD8+ T cells do not recognize lung APCs from infected mice. (a-d) T cell proliferation after coculture with lung APC from
infected mice, with or without cognate peptide, or uninfected TGPM, based on eFluor450 fluorescence dilution after 72 hours. Representative flow
plot (a) and quantification (b) of C7 T cell proliferation. Representative flow plot (c) and quantification (d) of TB10Rg3 T cell proliferation. (e)
Bacterial burden in the lung APCs during in vitro culture over the course of the experiment in the absence of T cells. Representative of 4 (TB10Rg3)
or 2 (C7) experiments.
https://doi.org/10.1371/journal.ppat.1007060.g004
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4LLO.TB10.4 or4ActA.TB10.4, respectively. Both are attenuated strains: the4LLO.TB10.4
mutant cannot escape from the vacuole, while the4ActA.TB10.4 mutant can escape from the
vacuole but not from the cell. Hence, the TB10.4 protein made by the4LLO.TB10.4 strain will
remain trapped in the phagosome, but the TB10.4 protein made by the4ActA.TB10.4 strain
will gain access to the cytosol.
TB10Rg3 T cells recognized4ActA.TB10.4-infected TGPMs based on an increased fre-
quency of Nur77-expressing cells (p<0.005) and the Nur77 MFI of all TB10Rg3 T cells
(p<0.005) (Fig 5A–5C). Bafilomycin, which inhibits vacuolar acidification and impairs the
entry of the4ActA.TB10.4 strain into the cytosol, diminished the frequency of Nur77-expres-
sing cells (p<0.005) and Nur77 MFI (p<0.01) (Fig 5A, top, Fig 5B and 5C). In contrast,
TB10Rg3 T cells co-cultured with4LLO.TB10.4-infected TGPMs showed no increase in the
frequency of Nur77-expressing cells or the Nur77 MFI (Fig 5A bottom, Fig 5D and 5E). If
recombinant listeriolysin (rLLO), the protein missing from the4LLO.TB10.4 strain, was
added to the infected macrophages, an increase in the frequency of Nur77-expressing
TB10Rg3 T cells (p<0.01) and the Nur77 MFI (p<0.01) became apparent. We also determined
whether P25 T cells recognized Ag85b-expressing Listeria monocytogenes using the recombi-
nant Listeria strains4ActA.Ag85b and4LLO.Ag85b. Based on the propensity of MHC class
II to present extracellular and vacuolar antigens, P25 cells recognized TGPMs infected with
either4ActA.Ag85b or4LLO.Ag85b, based on an increase in the frequency of Nur77-expres-
sing T cells and Nur77 MFI (p<0.005) (Fig 5G and 5H). These results show that 1) TGPMs
can efficiently process the full length TB10.4 protein and present the TB10.44−11 epitope via
MHC class I; 2) this process is more efficient when the bacteria are in the cytosol; and 3)
TB10Rg3 T cells can efficiently recognize TB10.44−11 presented during a live infection.
TB10.4-specific CD8+ T cells do not recognize Mtb overexpressing TB10.4
We considered several additional possibilities as to why the TB10Rg3 T cells did not recognize
Mtb-infected macrophages. Antigen abundance can affect T cell recognition, so we next tested
whether increasing the level of TB10.4 protein expression might enhance TB10Rg3 T cell rec-
ognition of Mtb-infected macrophages. Since Mtb secretes esxH (TB10.4) together with esxG
as a heterodimer [36], we developed a recombinant strain of H37Rv (esxGH-OE.Mtb), which
overexpresses both esxG and esxH under the control of a tetON promoter. After tetracycline
induction for 24 hours, we detected increased protein expression of TB10.4 (esxH) as well as
increased mRNA expression of esxG and esxH (Fig 6A and 6B). A second strain, Ag85b-OE.
Mtb, was used to show the specificity of the anti-TB10.4 antibody. When Ag85b was induced,
TB10.4 expression was unaltered (Fig 6A). The expression of GroEL2, a chaperonin protein,
was used as loading control and for normalization of protein signal (Fig 6A). When detecting
the mRNA expression, we probed for sigA, which encodes for a Mtb RNA polymerase factor,
and fbpB, which encodes for Ag85b, as well to verify that the esxGH-OE.Mtb strain specifically
overexpressed esxGH and not other proteins (Fig 6B). Prior to in vitro infection, we treated
esxGH-OE.Mtb with or without tetracycline. The next day, TGPMs were infected with
induced or uninduced esxGH-OE.Mtb. P25 T cells produced similar amounts of IFNγ when
co-cultured with macrophages infected with either uninduced or induced esxGH-OE.Mtb,
which was expected since Ag85b expression should not be altered (Fig 6C). Despite increasing
the production of TB10.4 by Mtb, TB10Rg3 T cells still did not recognize Mtb-infected macro-
phages (Fig 6D). Although we cannot be certain that the induction of EsxGH leads to an
increased amount of antigen delivered to the antigen processing pathway, this result suggests
that antigen abundance is not limiting TB10.4-specific CD8+ T cell recognition of Mtb-
infected macrophages.
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Mtb infection does not significantly impair MHC class I and II expression
by macrophages
We also investigated whether Mtb may inhibit MHC class I expression by infected TGPMs.
Mtb and TLR2 agonists inhibit IFNγ-induced MHC class II expression by bone marrow
derived macrophages, and the mycobacterial PPE38 protein can inhibit MHC class I expres-
sion in RAW264.7 macrophages and TGPMs infected with Mycobacterium smegmatis [37, 38].
Therefore, we asked whether Mtb impaired MHC class I expression in our in vitro infection
system, especially since the TGPMs were not pre-activated with IFNγ prior to infection. We
measured MHC class I and II expression by macrophages on each of the five days following
infection. At baseline, uninfected TGPMs expressed high MHC class I, and Mtb infection did
not alter MHC class I expression compared to the baseline (Fig 6E and 6F; solid lines). IFNγ
pretreatment of macrophages led to an increase in MHC class I expression by both uninfected
and infected TGPMs, although the infected cells expressed slightly less MHC class I (Fig 6E
and 6F; dotted lines). As expected, the regulation of MHC class II was more sensitive to IFNγ.
Uninfected TGPMs expressed low baseline levels of MHC class II (Fig 6G and 6H; solid lines).
IFNγ pretreatment resulted in a>100-fold increase in MHC class II median fluorescence
intensity (MFI) in the uninfected TGPMs, which peaked on day 3 with a>2000-fold increase
over the baseline (Fig 6G and 6H; dotted lines). Mtb-infection alone did not significantly affect
MHC class II expression, and consistent with previous studies, Mtb significantly impaired the
induction of MHC class II by IFNγ pretreatment (Fig 6G and 6H). These data show that, in
our in vitro infection model where the TGPMs were unstimulated, Mtb infection did not
inhibit class I and II MHC expression. Importantly, the differences in MHC class I or class II
expression by Mtb-infected macrophages cannot explain why P25 T cells, but not TB10Rg3 T
cells, recognized infected macrophages.
Macrophages cross-present antigens from non-viable Mtb to
TB10.4-specific CD8+ T cells
Next, we hypothesized that Mtb may interfere with MHC class I presentation of mycobacterial
antigens. Therefore, we tested the ability of the P25 and TB10Rg3 T cell lines to recognize
TGPMs cultured with γ-irradiated, nonviable Mtb. Activation of pattern recognition receptors
such as TLR2 and TLR4 by large amounts of dead bacteria might induce large amounts of IL-
12 and IL-18, resulting in cytokine-driven T cell activation. Taking this concern into consider-
ation, we used MHC-mismatched TGPMs as a control. We pulsed macrophages with a dose
titration of γ-irradiated Mtb, then added TB10Rg3 or P25 T cells, and measured IFNγ secre-
tion by the T cells after 72 hours. Both P25 and TB10Rg3 T cells produced high amounts of
IFNγ when cultured with MHC-matched (i.e., H-2b) but not with MHC-mismatched (i.e., H-
2k) TGPMs, and this response was dose dependent (Fig 6I and 6J). The ability of macrophages
to process and present TB10.4 after phagocytosing γ-irradiated Mtb but not viable bacteria
raises the possibility that live Mtb actively inhibit MHC class I presentation of TB10.4.
Fig 5. TB10Rg3 and P25 T cells can recognize macrophages infected with Listeriamonocytogenes expressing TB10.4 and Ag85b proteins, respectively. (a)
Representative flow plots showing Nur77 induction by TB10Rg3 T cells after co-culture with macrophages infected with4ActA.TB10 (top row) or4LLO.TB10
(bottom row) Listeria. (b) Analysis of the frequency of Nur77-expressing TB10Rg3 T cells (b, d), or normalized MFI (c, e), after co-culture with4ActA.TB10 (b, c) or
4LLO.TB10 (d, e) infected macrophages. (f) Representative flow plots showing Nur77 induction by P25 population after co-culture with macrophages infected with
4ActA.TB10 (top row) or4LLO.TB10 (bottom row) Listeria. (g) Analysis of the frequency of Nur77-expressing P25 T cells and (h) normalized MFI of P25 T cells.
Representative of at least two experiments. Statistical testing by one-way ANOVA with Dunnett posttest. , p<0.05; , p<0.01; and , p<0.005.
https://doi.org/10.1371/journal.ppat.1007060.g005
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Polyclonal, TB10.44−11-tetramer negative CD8
+ T cells from the lungs of
Mtb-infected mice recognize infected macrophages
Along with the previous finding that TB10.44−11-specific CD8
+ T cells make up ~40% of total
lung CD8+ T cells during infection (S5 Fig) [20], our finding that TB10Rg3 T cells do not rec-
ognize Mtb-infected macrophages suggests that TB10.4 may be a decoy antigen. This raises the
question whether the inability to recognize Mtb-infected macrophages is a general feature of
the CD8+ T cell response to Mtb, or if this is a unique feature of TB10.4-specific CD8+ T cells.
Therefore, we determined whether polyclonal CD8+ T cells from the lungs of infected mice
could recognize Mtb-infected macrophages. We carried out aerosol infection of C57BL/6 mice
with Erdman, and, 6–8 weeks post infection, we purified polyclonal CD4+ or CD8+ T cells
from their lungs and co-cultured them with Mtb-infected macrophages. After 72 hours of co-
culture, polyclonal CD4+ T cells produced high amounts of IFNγ in a MHC-restricted manner
(Fig 7A). Interestingly, polyclonal CD8+ T cells also produced IFNγ in a MHC-restricted man-
ner when co-cultured with Mtb-infected macrophages (Fig 7B). Although the polyclonal CD8+
T cells were contaminated by less than the 1.5% CD4+ T cells, we conducted experiments
using MHC I-/- macrophages and showed that the polyclonal CD8+ T cells produced signifi-
cant IFNγ only in the presence of MHC I was intact, excluding the possibility that the IFNγ
production was due to contaminating CD4+ T cells and showing that the Mtb-specific CD8+ T
cells were Kb or Db restricted (S6 Fig). These results indicate that other antigen-specific CD8+
T cells recognizing Mtb-infected macrophages do exist, and infected TGPMs can present Mtb
antigens to CD8+ T cells. However, based on the high abundance of TB10.4-specific CD8+ T
cells post infection (S5 Fig), the non-TB10.4-specific, Mtb-specific CD8+ T cells may be dwar-
fed by the dominant TB10.4-specific CD8+ T cells.
To better assess whether the IFNγ production by polyclonal CD8+ T cells arose predomi-
nantly from non-TB10.4-specific CD8+ T cells, we used the TB10.44−11-tetramer to separate
TB10.4-specific and non-TB10.4-specific, polyclonal CD8+ T cells from the lungs of infected
mice. After 72-hour co-culture with Mtb-infected macrophages, TB10.44−11-tetramer negative
CD8+ (non-TB10.4-specific CD8+) T cells produced significantly higher IFNγ compared to
that of uninfected control (p<0.005), and the production was MHC class I restricted (Fig 7C).
In contrast, TB10. 44−11-specific CD8
+ T cells produced IFNγ in a non-MHC-restricted man-
ner during co-culture with both uninfected and Mtb-infected macrophages (Fig 7D). We can-
not exclude the possibility that the tetramer isolation might have inadvertently activated the
TB10.44−11-specific CD8
+ T cells. Nevertheless, these data show that polyclonal, TB10.44−11-
tetramer negative CD8+ T cells recognized Mtb-infected macrophages, supporting the notion
of a subdominant T cell response that may be effective at detecting Mtb.
Fig 6. Probing potential mechanisms for lack of recognition by TB10Rg3 T cells. (a-c) EsxH (TB10.4) and its partner EsxG were
overexpressed together in H37Rv to determine whether increasing TB10.4 abundance would lead to recognition of infected
macrophages (esxGH-OE.Mtb). (a) Tetracycline treatment of esxGH-OE.Mtb in broth culture induces protein expression of EsxH
(TB10.4) as measured by western blot. A different strain, fbpB-OE.Mtb, in which fbpB (e.g., Ag85b) is induction by tetracycline, does
not result in greater EsxH (TB10.4) expression. Protein signal was normalized to that of GroEL2, a chaperonin protein. (b)
Tetracycline treatment of esxGH-OE.Mtb in broth culture induces esxG and esxH, but not fbpB (which encodes for Ag85b) and sigA
(which encodes for RNA polymerase factor sigma A), mRNA as measured by qPCR. Fold-induction was normalized to baseline (i.e.,
uninduced). IFNγ production by (c) P25 or (d) TB10Rg3 T cells after co-culture with macrophages infected with uninduced or
induced esxGH-OE.Mtb. (e-h) MHC class I and II expression by Mtb infected-macrophages. Representative histograms (e) and fold-
change (f) of MHC class I or representative histograms (g) and fold-change (h) of MHC class II expression on infected cells. (i) P25
and (j) TB10Rg3 production of IFNγ after co-culture with macrophages pulsed with titrated amounts of γ-irradiated (non-viable)
H37Rv. Data is representative of 3 experiments. Statistical testing by one-way ANOVA with Dunnett posttest. , p<0.05; , p<0.01;
and , p<0.005.
https://doi.org/10.1371/journal.ppat.1007060.g006
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Fig 7. Polyclonal CD8+ T cells from the lungs of Mtb-infected mice recognize infected macrophages. IFNγ production by polyclonal CD4+ (a) or
CD8+ (b) T cells after co-culture with either MHC-matched (H-2b) or MHC-mismatched (H-2k), Mtb-infected macrophages. IFNγ production by
TB10.44−11-tetramer-depleted (c) or tetramer-enriched (d) polyclonal CD8
+ T cells after co-culture with either MHC-matched (H-2b) or MHC-
mismatched (H-2k), Mtb-infected macrophages. Data is representative of at least 2 experiments. Statistical testing by a two-tailed, unpaired Student’s T
test. , p<0.05; , p<0.01; and , p<0.005.
https://doi.org/10.1371/journal.ppat.1007060.g007
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Discussion
A complexity in defining T cell recognition is distinguishing cognate from non-cognate recog-
nition. T cell IFNγ production, a common readout for recognition, can be stimulated by IL-12
and IL-18, two cytokines secreted by Mtb-infected cells [27, 29–31]. Even cognate recognition
does not always signify recognition of infected cells. Uninfected macrophages and dendritic
cells (DCs) can acquire exosomes, soluble proteins, apoptotic vesicles or necrotic debris con-
taining non-viable bacilli or its antigens, and present these to T cells [13, 39–41]. This detour
pathway allows T cells to be activated by uninfected DCs [39, 42]. Thus, T cell recognition of
infected macrophages, which is central to our fundamental paradigm of TB pathogenesis,
remains poorly defined.
Our study advances the understanding of T cell recognition of Mtb-infected cells. By focus-
ing on TCR-mediated recognition, our data show that T cells specific to immunodominant
antigens vary in their ability to recognize Mtb-infected macrophages. Despite being a persis-
tent and dominant population of CD8+ T cells in the lungs of Mtb-infected mice, TB10.44−11-
specific CD8+ T cells do not recognize Mtb-infected macrophages. While we primarily used
TGPMs, which have been used to model human macrophages [43, 44], we also showed that
TB10.4-specific CD8+ T cells failed to recognize lung APCs from infected mice. Importantly,
concurrent with our analysis of CD8+ T cells, we systematically assessed recognition of Mtb-
infected macrophages by Ag85b-specific (i.e., P25) and ESAT-6-specific (i.e., C7) CD4+ T
cells. Both recognized Mtb-infected macrophages and inhibited bacterial growth (here and
[10]). Thus, under conditions that activated Mtb-specific CD4+ T cells, no activation of
TB10.4-specific CD8+ T cells occurred. This finding has many implications, among which the
most important is that not all Mtb-specific T cells recognize Mtb-infected macrophages.
These results led us to re-examine the evidence that CD8+ T cells recognize infected cells.
In our evaluation of the literature, among the best evidence is: (1) direct ex vivo recognition of
Mtb-infected macrophages and DC by CD4+ and CD8+ T cells [45–48]; (2) murine T cells’
cytolytic activity (CTL) of MTb-infected cells [49–51]; (3) human CD8+ T cells that recognize
Mtb-infected DC [52–54]. However, these data have limitations. The murine studies never
demonstrated cognate recognition, and the frequencies were lower than expected. The human
studies only used DC and not macrophages and used a high MOI, raising concerns about
death of infected cells and presentation of nonviable antigen. Nevertheless, these studies sup-
port the idea that CD8+ T cells recognize infected cells, but their frequency that recognize
infected macrophages might be lower than we previously expected. Such a finding might
explain why CD8+ T cells make a disproportionately small contribution to host defense, even
though Mtb infection elicits a robust CD8+ T cell response.
We investigated several mechanisms that might explain why TB10.4-specific CD8+ T cells
do not recognize infected macrophages. One possibility is the access of the TB10.4 antigen to
the MHC class I processing pathway. Mtb can disrupt the phagosomal membrane and translo-
cate into the cytosol [55], though this action often occurs later in infection and leads to necro-
sis of the macrophage [56]. We saw no evidence of recognition even at late time points such as
days 4–5 post infection (Fig 3), when phagosomal disruption and bacterial translocation
occurs [56]. The importance of antigen location became apparent during the Listeria infection
experiments, where infected macrophages presented TB10.44−11 only when the bacteria could
enter the cytosol (i.e.,4ActA.TB10 but not4LLO.TB10). The Listeria experiments also pro-
vided an additional insight. Lindenstrom et al report that vaccination with TB10.4 (EsxH),
which has a leucine at position 12 (i.e., IMYNYPAML), inefficiently generates TB10.4-specific
CD8+ T cells [57]. However, vaccination with TB10.3 (EsxR), a related antigen that also con-
tains the same epitope followed by a methionine (i.e., IMYNYPAMM), elicits TB10.4-specific
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CD8+ T cells. Based on that finding, they conclude there is a processing defect that prevents
the generation of the TB10.44−11 epitope from the TB10.4 protein. However, they also find that
TB10.4-specific CD8+ T cells elicited by TB10.3 vaccination recognize splenocytes pulsed with
the rTB10.4 proteins, showing that the full length TB10.4 protein can be processed and pre-
sented. These data indicate that the lack of vaccine-elicited TB10.4-specific CD8+ T cells is due
to a problem with priming after vaccination instead of an inability to process the IMYNYPAM
epitope. Moreover, our data using TB10.4-expressing Listeria show that TGPMs can process
the full length TB10.4 protein and present the TB10.44−11 epitope. Therefore, we conclude that
amino acid sequence of TB10.4 does not hinder its processing. The Listeria experiments also
show the potential importance of antigen location and raise the possibility that sequestration
of the TB10.4 antigen in the phagosome renders it inaccessible to the MHC class I presentation
pathway.
Low antigen abundance could also explain the lack of recognition. We have previously
argued that there is limited amount of TB10.4 antigen presentation in the lungs of infected
mice, leading to extreme bias in the TCR repertoire of the TB10.4-specific CD8+ T cell response
and defects in the memory-recall response in vivo [20, 24]. Importantly, bacterial TB10.4 levels
are regulated by iron availability, and its expression varies in different growth medias [58].
Tinaztepe et al showed that, while H37Rv grown in 7H9 media reduced its TB10.4 expression in
broth culture, the bacteria, during subsequent infection in BMDMs, required TB10.4 to remain
virulent and survive in the BMDMs [58]. To test the possibility of low antigen abundance, we
overexpressed EsxG and EsxH (TB10.4) together but did not see greater T cell recognition of
Mtb-infected macrophages, suggesting that abundance might not be the issue.
Unexpectedly, macrophages pulsed with γ-irradiated Mtb were recognized by TB10.4-spe-
cific CD8+ T cells, raising the possibility that live Mtb actively inhibits MHC class I presenta-
tion of TB10.4. This is particularly interesting since the presentation of CFP10, another ESAT-
6-like protein, by human DCs to CD8+ T cells requires viable Mtb; DCs given heat-killed bac-
teria do not present CFP10 to T cells [54]. While these data suggest that presentation requires
active secretion of CFP10 [59, 60], the heat-killing process could have destroyed CFP10, or
there might not have been sufficient amounts of CFP10 available in the non-viable bacteria. In
combination with our data showing polyclonal CD8+ T cells recognize Mtb infected macro-
phages, these data show that it is possible that certain antigens are presented by live Mtb while
others are actively prevented from being sampled by MHC class I. A caveat to these studies is
the amount of TB10.4 present in the γ-irradiated bacteria could differ from the live bacteria
because of differences in the culture conditions. The H37Rv used for γ-irradiation was grown
in the Glycerol-Alanine-Salt (GAS) minimal media whereas the H37Rv used for all other
experiments was grown in 7H9 media supplemented with OADC, Tween80 and glycerol. As
both media contain iron (from the FBS in 7H9 media or from the ferric ammonium citrate in
GAS media), and that iron is the key regulator of TB10.4 expression, we do not expect that dif-
ferences in the culture media would interfere with the outcomes of the experiments.
Ag85b is an immunodominant antigen with an epitope recognized by CD4+ T cells in
C57BL/6 mice. In vivo data shows that Ag85b-specific CD4+ T cells can recognize Mtb-
infected cells early during infection; however, recognition decreases after infection is estab-
lished [12, 14, 15, 61, 62]. The inability of Ag85b-specific CD4+ T cells to efficiently recog-
nize Mtb-infected bone-marrow derived macrophages (BMDMs) or bone-marrow derived
dendritic cells (BMDCs) stems from a combination of reduced Ag85b expression by Mtb
and because infected cells actively export Ag85b into the extracellular milieu [12, 13]. In our
experiments, we found that P25 T cells recognized Mtb-infected macrophages and inhibited
bacterial growth in a MHC-restricted manner. A difference between the studies is the dura-
tion of macrophage and T cell co-culture. Grace et al examined 16–24 hours and found a
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lack of recognition, whereas our assays focused on 72–96 hours and detected recognition.
Moreover, it is unknown whether Mtb-infected cells still exported antigens after the initial
24 hours of infection. Furthermore, the exported Ag85b could be taken up by infected cells
during longer co-cultures, leading to their recognition by T cells. Finally, it is possible that
cognate recognition of uninfected cells that present Ag85b could activate CD4+ T cells in a
TCR-mediated manner, inducing IFNγ and indirectly controlling Mtb replication in mac-
rophages. Nonetheless, under conditions that activate Mtb-specific CD4+ T cells, we could
not observe activation of TB10.4-specific CD8+ T cells.
The TB10.44−11 epitope has been extensively used to characterize CD8
+ T cell responses in
the mouse model of TB, and TB10.4-specific CD8+ T cell responses have also been character-
ized in people with tuberculosis [20, 22, 24, 57, 63–65]. The finding that TB10.4-specific CD8+
T cells do not recognize infected macrophages was unexpected, particularly since TB10.4-spe-
cific CD8+ T cells persist in the lungs of infected mice and become more dominant with time
[19, 20]. From these experiments, two questions warrant further investigation: 1) whether the
CD8+ T cells specific to other epitopes of TB10.4 also inefficiently recognize infected macro-
phages, and 2) whether the species or the host genetic background influence recognition of
infected cells.
In retrospect, our findings may partially explain why eliciting TB10.4-specific CD8+ T cells
by vaccination fails to protect mice against Mtb infection [24, 57]. While vaccination with
immunodominant antigens recognized by CD4+ T cells (e.g., Ag85b, ESAT-6) induce moder-
ate protection [66, 67], we must consider the possibility that these antigens may not be the best
stimulators of protective immunity. Ag85b-specific CD4+ T cells have variable efficacy, in
large part due to its reduced expression by the bacterium as early as 3 weeks after infection [11,
12]. However, by their nature, the recruitment of memory T cell responses specific for immu-
nodominant antigens is only incrementally faster than the primary T cell response [10, 24].
Thus, a crucial question for vaccine development is whether other Mtb antigens resemble
TB10.4, in that they elicit T cell responses that fail to recognize infected macrophages. We did
detect polyclonal CD8+ T cells that recognized Mtb infected macrophages, corroborating a
previous study showing that polyclonal CD8+ T cells from infected mice can lyse Mtb-infected
cells [49]. These data indicate that there are antigens presented by Mtb-infected cells, even if
those antigens may be subdominant compared to TB10.4. Thus, future vaccine developments
will benefit by identifying antigen targets based on their ability of being presented rather than
only their immunogenicity.
Priming of TB10.4-specific CD8+ T cells occurs early after Mtb infection in the lung drain-
ing lymph node (LN) [24, 68]. Yet it is unknown whether priming of naïve T cells occurs via
Mtb-infected DCs, or uninfected DCs that acquire antigen through uptake of apoptotic blebs
containing Mtb proteins [39, 42], or by the transfer of antigen from cell to cell [41]. Priming
by an uninfected cell can have detrimental consequences if the infected cell presents a different
repertoire of Mtb antigens. Considering our findings, we propose that TB10.4 is a decoy anti-
gen: TB10.4-specific CD8+ T cells expand in the LN during priming, accumulate in the lungs,
but ineffectively recognize Mtb-infected macrophages. This raises the hypothesis that not all
immune responses elicited by Mtb provide benefits to the host. Interestingly, Mtb genes
encoding epitopes recognized by T cells are more highly conserved than other DNA elements,
implying that T cell recognition of these Mtb epitopes may provide a survival advantage to the
bacterium [69, 70]. For example, T cell dependent inflammation may benefit Mtb by promot-
ing transmission. Even though TB10.4 is more variable than most other antigens, our results
support these genetic data [69, 70]. Thus, Mtb focuses the CD8+ T cell response on the decoy
antigen TB10.4 and distracts the immune response from other antigens that might be targets
of protective immunity, successfully evading T cell immunity and enabling it to establish itself
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as persistent infection. Although we do not yet know whether the phenomenon we have
described for TB10.4 will be true for other antigens, our data do reveal the hazards of selecting
vaccine antigens based on immunogenicity and immunodominance alone. We propose that




Studies involving animals were conducted following relevant guidelines and regulations, and
the studies were approved by the Institutional Animal Care and Use Committee at the Univer-
sity of Massachusetts Medical School (Animal Welfare A3306-01), using the recommendations
from the Guide for the Care and Use of Laboratory Animals of the National Institutes of
Health and the Office of Laboratory Animal Welfare.
Mice
C57BL/6J, Rag-1-deficient (B6.129S7-Rag1tm1Mom), B10 (C57BL/10J), B10.BR (B10.BR-H2k2
H2-T18a/SgSnJJrep), P25 (C57BL/6-Tg(H-2Kb-Tcrα,Tcrβ)P25Ktk/J) [25, 71], mice were
obtained from Jackson Laboratories (Bar Harbor, ME). C57BL/6J and B10 mice were used for
isolating MHC-matched TGPMs while B10.BR mice were used for isolating MHC-mismatched
TGPMs. C57BL/6 Kb-/-Db-/- (MHC I-/-) mice were a generous gift from Dr. Kenneth Rock (Uni-
versity of Massachusetts Medical School, MA). C7 TCR transgenic mice were a generous gift
from Dr. Eric Pamer (Memorial Sloan Kettering Cancer Center, NY)[35].
Thioglycolate-elicited peritoneal macrophages
Thioglycolate-elicited peritoneal macrophages were obtained 4–5 days after intra-peritoneal
injection of mice with 3% thioglycolate solution, as described [29]. 1×105 macrophages were
plated per well. Macrophages were maintained in culture with RPMI 1640 media (Invitrogen
Life Technologies, ThermoFisher, Waltham, MA) supplemented with 10 mM HEPES, 1 mM
sodium pyruvate, 2 mM L-glutamine (all from Invitrogen Life Technologies) and 10% heat-
inactivated fetal bovine serum (HyClone, GE Healthcare Life Sciences, Pittsburgh, PA),
referred hereafter as supplemented complete media.
Generation of CD8+ and CD4+ T cell lines
Retrogenic mice expressing TB10Rg3 TCR specific for the TB10.44−11 epitope were generated
as previously described [20]. The TB10Rg3 CD8+ T cells were isolated from these mice, stimu-
lated in vitro with irradiated splenocytes pulsed with the peptide TB10.44−11 in complete media
containing IL-2. P25 or C7 CD4+ T cells were isolated from transgenic P25 or C7 mice, respec-
tively [25, 35]. The P25 and C7 cells were stimulated in vitro with irradiated splenocytes pulsed
with the Ag85b240-254 peptide or the ESAT-63−17, respectively, in complete media containing
IL-2 and anti-IL-4. After the initial stimulation, these T cells were split every two days for 3–4
divisions and rested for two to three weeks. After the initial stimulation, the cells were cultured
in complete media containing IL-2 and IL-7.
Peptides
The following synthetic peptide epitopes were used as antigens: TB10.44−11 (IMYNYPAM);
Ag85b240-254 (FQDAYNAAGGHNAVF); and ESAT-63−17 (EQQWNFAGIEAAASA). We also
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generated a negative control peptide predicted to not bind to H-2 Kb: IMANAPAM. The pep-
tides were obtained from New England Peptides (Gardner, MA).
As positive controls for assessing the function of macrophages to present antigen, unin-
fected macrophages and, in certain experiments, infected macrophages were pulsed with the
peptides of interest. We pulsed macrophages by incubating 10uM of the peptides of interest
with the macrophages in supplemented complete RPMI 1640 media for 1 hour. After incuba-
tion, the cells were washed 3 to 5 times with fresh supplemented complete RPMI 1640 media.
The cells were then resuspended in supplemented complete RPMI 1640 media for
experiments.
In vitro Mtb infection
H37Rv was grown as previously described [29]. Bacteria was grown in BD Difco Middlebrook
7H9 (Thermo Fisher, Waltham, MA) supplemented with 10% OADC (Sigma-Aldrich,
St. Louis, MO), 0.2% glycerol and 0.05% Tween-80 (both from Thermo Fisher) to an OD600 of
0.6–1.0, washed in RPMI, opsonized with TB coat (RPMI 1640, 1% heat-inactivated FBS, 2%
human serum, 0.05% Tween-80), washed again and filtered through a 5 micron filter to remove
bacterial clumps. The bacteria were counted using a Petroff-Hausser chamber. Infection was
performed as previously described [29]. The final multiplicity of infection (MOI), based on plat-
ing CFU, was 0.2–0.8 for all experiments, unless otherwise indicated. For CFU-based, bacterial
growth inhibition assays, T cells were added at a ratio of 5 T cells to each macrophage. Four rep-
licate wells were used for each condition. Cell cultures were lysed by adding 1/10th volume of
with 10% Triton X-100 in PBS (final concentration of 1%), and CFUs were determined by plat-
ing in serial dilutions of the lysates on Middlebrook 7H10 plates (Hardy Diagnostics, Santa
Maria, CA). CFUs were enumerated after culture for 21 days at 37˚C and 5% CO2.
In vivo aerosol Mtb infection and lung cell isolation
Aerosol infection of mice was done with the Erdman strain of Mtb using a Glas-Col aerosol-
generation device. A bacterial aliquot was thawed, sonicated for 1 minute and then diluted in
0.9% NaCl-0.02% Tween-80 to 5 ml. The number of Mtb deposited in the lungs was deter-
mined for each experiment, by plating undiluted lung homogenate from a subset of the
infected mice within 24 hours of infection. The inoculum varied between 37–120 CFU. For the
ex vivo APC experiments, lung cells were isolated from Erdman-infected, RAG-1-deficient
mice, 4-weeks post-infection, and the APCs were enriched by positive selection using anti-
MHC class II+ microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany) and the Miltenyi
AutoMACS. On average, the isolated cells were 89% CD11c+ or CD11c+CD11b+. The APCs
were counted on a hemocytometer and plated at 1x105 per well in supplemented complete
RPMI 1640 media.
For the ex vivo CD4+ and CD8+ T cell experiments, single cell suspensions were isolated
from the lungs of infected C57BL/6 mice, 6 to 8 weeks post-infection, as described [10]. Poly-
clonal CD4+ and CD8+ T cells were enriched by positive selection using Mouse CD4+ and
Mouse CD8+ T cell isolation kits, respectively (Miltenyi Biotec). After enrichment, average
purity for polyclonal CD4+ and CD8+ T cells were 93% and 95%, respectively. For experiments
investigating TB10.44−11-tetramer positive cells and polyclonal, non-TB10.4-specific, CD8
+ T
cells, the following isolation was done. Single cell suspensions from the lungs of infected mice
were incubated with APC-conjugated, TB10.4−4-11-loaded, H-2b tetramers from the National
Institute of Health Tetramer Core Facility (Emory University Vaccine Center, Atlanta, GA).
Tetramer positive CD8+ T cells were then selected via the AutoMACS separator by anti-APC
microbeads (Miltenyi Biotec). Average purity of TB10.44−11-tetramer positive, CD8
+ T cells
T cell recognition of Mtb-infected macrophages
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1007060 May 21, 2018 21 / 30
was 85%, with 1.4% contaminating CD4+ T cells. The tetramer negative population was subse-
quently washed and then enriched for polyclonal CD8+ T cells via Mouse CD8+ T cell isolation
kit (Miltenyi Biotec). Average purity of polyclonal, non-TB10.44−11-tetramer positive, CD8
+ T
cells was 75% with 0.8% contaminating CD4+ T cells and 13% contaminating TB10.44−11-tetra-
mer positive CD8+ T cells. The T cells were counted using a hemocytometer and resuspended
in supplemented complete RPMI 1640 media before being used in experiments.
Listeria infections
The recombinant Listeria strains have been previously described [24]. For in vitro infections,
they were grown to an OD600 of 0.6–1.0 in BHI media (Sigma Aldrich) with 10 ug/ml chloram-
phenicol (Sigma Aldrich) at 30˚C. Macrophages were infected with the Listeria strains using a
MOI 50, for 45 minutes. Extracellular bacteria were eliminated by adding 60 ug/ml gentamicin
(Sigma Aldrich) for 20 minutes. Bacterial burden was assessed by lysing the infected macro-
phages with 1% TritonX-100 in PBS, and plating serial dilutions of the lysate on BHI agarose
supplemented with 10ug/ml chloramphenicol (Sigma Aldrich, St. Louis, MO). Recombinant
listeriolysin (Prospec, East Brunswick, NJ) was added in some experiments at 2 ug/ml for 30
minutes, and any excess was washed away. Bafilomycin (InvivoGen, San Diego, CA) was
added in some experiments at 5 uM for 30 minute, before being washed away.
Generation of TB10.4-overexpressing Mtb strains
pJR1103 was cleaved with EcoRI-HF and SalI-HF [72]. mCherry preceded by the groEL2 pro-
moter from H37Rv was inserted by HiFi Assembly. The resulting plasmid was cleaved with
NdeI and NotI-HF. The esxGH gene from H37Rv, along with 12 upstream nucleotides, was
inserted by HiFi Assembly following the plasmid-borne tetracycline-inducible promoter. All
enzymes used above were purchased from New England Biolabs. The resulting plasmid
(pGB6) was electroporated into Mtb H37Rv and integrated at the L5 site. RNA was purified
from induced and uninduced cultures using TRIzol (ThermoFisher) and chloroform extrac-
tion, followed by purification on Zymo columns. cDNA was produced with Superscript IV
(ThermoFisher), and quantitative PCR was performed using the iTaq SYBR Green Supermix
(Bio-Rad, Hercules, CA) on an Applied Biosystems Viia 7 thermocycler.
For confirmation of overexpression of TB10.4 (esxH), western blot was performed. Strains
were induced in mid log phase with anhydrotetracycline (ATc) for 24 hours. Bacterial pellets
were washed and resuspended in PBS + protease inhibitor, then heat-inactivated for 2h @ 80–
90˚C and lysed by bead beating. Lysates were clarified by centrifugation and separated by elec-
trophoresis (~2 μg protein per lane). Proteins were transferred onto nitrocellulose and probed
with primary antibodies against TB10.4 (esxH) at 1:400 concentration (Antibodies-Online,
Atlanta, GA) and GroEL2 (Hsp60/65) at 1:1000 concentration (GeneTex, Irving, CA). Anti-
rabbit 680 (for esxH) and anti-mouse 800 (for GroEL2) were used at 1:15,000 concentration
(both from LI-COR Biosciences, Lincoln, NE). PageRuler Plus Prestained (ThermoFisher)
protein ladder was used. Antibody incubations were done in MB-070 blocking buffer (Rock-
land, Limerick, PA). Infrared detection was done on a LI-COR Odyssey CLx. Quantification
was performed using LI-COR ImageStudio software. Strain fbpB.OE-Mtb is a Mtb strain
made to overexpress fbpB (Ag85b) protein and acts as a specificity control as ATc treatment of
this strain is not expected to increase the TB10.4 protein.
Irradiated H37Rv
The following reagent was obtained through BEI Resources, NIAID, NIH: Mycobacterium
tuberculosis, Strain H37Rv, Gamma-Irradiated Whole Cells, NR-14819. The irradiated H37Rv
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was gently sonicated using a cup-horn sonicator at a low power to disperse bacterial clumps
while limiting bacterial lysis. The number of bacteria, or antigen load, was approximated by
measuring the turbidity at OD600, and correlating it with live H37Rv (OD600 = 1 is equivalent
to 3.0x108 CFU/ml). To pulse TGPMs, diluted, sonicated, γ-irradiated H37Rv were added to
adherent macrophages for one hour before repeatedly washing the cultures to remove residual
extracellular bacteria. Subsequently, TB10Rg3 or P25 T cells were added at a ratio of 1 T cell to
1 macrophages. After 72 hours, the amount of IFNγ in the supernatants was measured using
Mouse IFNγ ELISA MAX kits (Biolegend, San Diego, CA).
Flow cytometry analysis
The following cell surface antigens were detected by flow cytometry using the following
antibodies: mouse CD4 (clone GK1.5), CD8 (clone 53–6.7), CD3ε (clone 145-2C11), CD69
(clone H1.2F3), I-A/I-E (clone M5/114.15.2), and H-2Kb (clone AF6-88.5) (all from Biole-
gend). BV421- and APC-conjugated, TB10.44−11-loaded, H-2K
b tetramers were obtained
from the National Institutes of Health Tetramer Core Facility (Emory University Vaccine
Center, Atlanta, GA). Zombie Violet Fixable viability dye (Biolegend) or the Live/Dead Fix-
able Far Red Dead Cell stain (ThermoFisher) were used for distinguishing live from dead
cells. To stain for the Nur77 transcription factor, the Nur77 monoclonal antibody (clone
12.14) was used in combination with the Foxp3 Transcription Factor Staining Buffer Set
(both from ThermoFisher) by the manufacturer’s protocol. Live/dead viability staining and
surface staining were done for 20 minutes at 4˚C, and intracellular staining was done for 30
minutes at room temperature. Samples were then fixed with 1% paraformaldehyde/PBS for
1 hour before being analyzed by a MACSQuant flow cytometer (Miltenyi Biotec). FlowJo
Software (Tree Star, Portland, OR) was used to analyze the collected data. Single lympho-
cytes were gated by forward scatter versus height and side scatter for size and granularity,
and dead cells were excluded.
Normalization and statistical analysis
To compare the cellular expression of Nur77 and CD69 expression levels between time points,
the MFI values were normalized as follows: experimental values were divided by the difference
between the isotype control MFI (minimum response) and the peptide control MFI (maxi-
mum response).
Each figure represents a minimum of 2 similar experiments, with 2 to 4 biological replicates
in each experiment. Data are represented as mean ± standard error of the mean (SEM). For
comparing two groups, a two-tailed, unpaired student’s t-test was used. For more than two
groups, the data were analyzed using a one-way ANOVA. A p value < 0.05 was considered to
be statistically significant. Analysis was performed using GraphPad Prism, Ver. 7 (GraphPad
Software, La Jolla, CA).
Supporting information
S1 Fig. P25 T cells specifically respond to specifically to the Ag85b240-254 epitope. MHC-
matched (H-2b) and MHC-mismatched (H-2k) macrophages were pulsed with 10 μM of
Ag85b240-254 or TB10.44−11 synthetic peptides. After 1 hour, unbound peptides were washed
out, and P25 T cells were added for 72 hours. Induction of CD69 was measured by flow cytom-
etry and IFNγ was measured by ELISA. The normalized CD69 MFI (a) and IFNγ (b) produced
by P25 T cells were measured. Data representative of 3 experiments.
(PDF)
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S2 Fig. TCR analysis and cloning of TCRs expressed by TB10.44−11-specific CD8
+ T cells
from the lungs of Mtb-infected C57BL/6 mice. Mononuclear lung cells were obtained from
three individual C57BL/6 mice, 9 weeks after low-dose aerosol infection with Mtb Erdman.
Single TB10.44−11-tetramer
+ CD8+ T cells from each mouse were sorted into 96-well plates
and the CDR3α and CDR3β sequences determined as described [20]. The analysis of a repre-
sentative mouse is shown, for which 141 CDR3α sequences was determined. A clonal expan-
sion of TB10.44−11-tetramer
+CD8+ T cells, as previously described [20], was suggested by the
skewed distribution of TRAV and TRAJ families (a), which shows an extreme bias in the use
of TRAV7 and TRAJ15 gene segments, as well as a dominant CDR3α amino acid (aa) length
of 12 (b). (c) Analysis of all CDR3α aa sequence with a length of 12 (n = 112) identify a consen-
sus motif of CAVSGGGRALIF for TB10.44−11-specific CD8
+ T cells. Amplification of CDR3α
and CDR3β sequences from the same well allowed pairing of TCRα and TCRβ for individual
TB10.44−11-specific CD8
+ T cells. Three individual mice were analyzed in this manner (d). We
identified an expanded CDR3β sequence containing the “xDRENSD” motif, the same motif
that had been previously defined by NexGen sequencing [20]. Thus, mouse L1 had an expan-
sion of CD8+ T cells with the CASSLDRENDYTF CDR3β sequence, mouse L2 was dominated
by CD8+ T cells using the CDR3β sequence CASSQDRENDYTF, and mouse L3 expressed two
major expansions, one encoding CASSLDRENDYTF and the other, CASSDDRENDYTF (d).
Based on our ability to pair the CDR3α and CDR3β sequences, we detected an interesting
reciprocal conservation. Namely, the ‘xDRENSD’ CDR3β motif was matched to a ‘SxGGRA’
CDR3α motif (e). Finally, we identified an expansion of a T cell clone in mouse L1, which
expressed a novel sequence that we had not previously observed (i.e., CASSPDRGNTGQLYF)
(d, e). Thus, with a high degree of confidence, we paired the CDR3α and CDR3β sequences
belonging to 5 distinct TB10.44−11-specific CD8
+ T cell clones that had been expanded in lungs
of Mtb-infected C57BL/6 mice. The TCRα and TCRβ cDNAs were reconstructed and cloned
using standard methods, and retrogenic mice were subsequently produced [20, 73, 74].
(PDF)
S3 Fig. Reconstitution and expression of specific TCRs in C57BL/6 retrogenic mice. Retro-
genic mice were produced as previously described [20]. Six weeks after retroviral transduction
of bone marrow and reconstitution of congenically marked recipient mice, the expression of
the recombinant TCR was determined in peripheral blood. (a) The BW58α-β- cell line was
transduced with different retroviral constructs. GFP+ cells were sorted three times, and mAbs
specific for Vα or Vβ were used to confirm successful TCR expression and pairing of TB10RgP
and TB10RgLD. The TB10Rg3 construct was included as internal control. (b) Representative
flow cytometry plots showed gating strategy of donor-derived GFP+ specific Vβ+ TB10.44−11-
tetramer+ CD8+ TB10RgR and TB10RgLD mice. (c) Representative flow cytometry plots of
splenic T cells from TB10RgP retrogenic mice demonstrating CD8+GFP+ T cells staining with
the TB10.44−11-tetramer.
(PDF)
S4 Fig. TB10Rg3 CD8 T cells do not recognize macrophages infected at high MOI. To
determine whether a higher MOI would lead to more TB10 antigen production and presenta-
tion to TB10Rg3 CD8 T cells, TGPMs were infected with H37Rv at high MOI (average effec-
tive MOI of 1.65 to 5.98). TB10Rg3 T cells were added on d1 and d2 post infection for 2 hours,
and their expression of Nur77 (a) and CD69 (b) were quantified. Data representative of at least
2 experiments for each time point.
(PDF)
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S5 Fig. TB10.44−11-tetramer positive CD8
+ dominates the pulmonary CD8+ T cell response
during Mtb infection in C57BL/6 mice. Representative flow plot showing the percent of
TB10.44−11-tetramer positive CD8
+ T cells among lung cells isolated from mice infected with
Mtb Erdman via the aerosol route 6 weeks post-infection. Total lung mononuclear cells were
stained with antibodies and tetramers and analyzed by flow cytometry. Lymphocytes were
gated based on forward and side scatter and doublets were excluded. CD8 cells were distin-
guished from CD4 cells. TB10.4-tetramer+ CD8s were identified among the CD8 cell popula-
tion.
(PDF)
S6 Fig. Polyclonal CD8+ T cells recognition of Mtb-infected macrophages requires MHC I
expression. Polyclonal CD8+ T cells were purified from the lungs of C57BL/6J mice, and
immediately cultured with either WT (H-2b mφ) or KbDb-/- (MHC I-/- mφ). After 72 hours,
IFNγ in the cultures was measured by ELISA. Data is representative of 2 experiments. Statisti-
cal testing by a two-tailed, unpaired Student’s T test. , p<0.05; , p<0.01; and , p<0.005.
(PDF)
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